Key points are not available for this paper at this time.
Our findings, add to the growing evidence, that we should reconsider what constitutes alert symptoms for early tubo-ovarian cancer. We need a more nuanced complex of key symptoms which is then evaluated and refined in a prospective trial.
Dilley et al. (Sat,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: